| SARS-CoV | Severe Acute Respiratory Syndrome Coronavirus |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| MERS-CoV | Middle East Respiratory Syndrome Coronavirus |
| CoVs | Coronaviruses |
| H1N1 | Hemagglutinin Type 1 and Neuraminidase Type 1 (Influenza A subtype) |
| HIV-1 | Human Immunodeficiency Virus Type 1 |
| mRNA | Messenger Ribonucleic Acid |
| VLPs | Virus-Like Particles |
| IVA | Influenza Virus A |
| DENV | Dengue Virus |
| ZIKV | Zika Virus |
| EBOV | Ebola Virus |
| MPXV | Monkeypox Virus |
| RNA | Ribonucleic Acid |
| RNP | Ribonucleoprotein |
| DNA | Deoxyribonucleic Acid |
| S protein | Spike Protein |
| ACE2 | Angiotensin-Converting Enzyme 2 |
| DPP4 | Dipeptidyl Peptidase 4 |
| TMPRSS2 | Transmembrane Protease Serine 2 |
| NP | Nucleoprotein |
| VP | Viral Protein |
| GP | Glycoprotein |
| sGP | Soluble GP |
| L | Polymerase |
| NTPase | Nucleoside Triphosphatase |
| HA | Hemagglutinin |
| vRNP | Viral Ribonucleoprotein Complex |
| E protein | Envelope Protein |
| CD4 | Cluster of Differentiation 4 |
| CCR5 | C-C Chemokine Receptor Type 5 |
| CXCR4 | C-X-C Chemokine Receptor Type 4 |
| NPC1 | Niemann–Pick C1 Protein |
| E8L | A Viral Envelope Protein from MPXV |
| EGCG | Epigallocatechin Gallate |
| ASA, ASAI | Allium Sativum Lectins |
| IC50 | Half Maximal Inhibitory Concentration |
| FRET | Förster Resonance Energy Transfer |
| Mpro/3CLpro | Main Protease/3-Chymotrypsin-Like Protease (also nsp5) |
| PLpro | Papain-Like Protease (also nsp3) |
| NSPs | Non-Structural Proteins |
| RdRp | RNA-Dependent RNA Polymerase (also nsp12) |
| RTC | Replication–Transcription Complex |
| ER | Endoplasmic Reticulum |
| ERGIC | Endoplasmic Reticulum–Golgi Intermediate Compartment |
| IRES | Internal Ribosome Entry Site |
| RT | Reverse Transcriptase |
| GAGs | Glycosaminoglycans |
| DC-SIGN/L-SIGN | Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-Integrin/Liver/Lymph Node-Specific ICAM-3-Grabbing Integrin |
| TIM-1 | T-cell Immunoglobulin and Mucin-Domain-Containing-1 |
| PI3K/Akt | Phosphoinositide 3-Kinase/Protein Kinase B pathway |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| PMF | Plant Molecular Farming |
| DSP | Downstream Processing |
| HIV | Human Immunodeficiency Virus |
| TMV | Tobacco Mosaic Virus |
| CPMV | Cowpea Mosaic Virus |
| HPV16 | Human Papillomavirus 16 |
| AMV | Alfalfa Mosaic Virus |
| BaMV | Bamboo Mosaic Virus-Based |
| FMDV | Foot-and-Mouth Disease Virus |
| AP 205 | Bacteriophage AP 205 |
| HBV | Hepatitis B Virus |
| HEV | Hepatitis E Virus |
| BTV | Bluetongue Virus |
| AHSV | African Horse Sickness Virus |
| mAb | Monoclonal Antibody |
| KDEL | Retention Signal Sequence in Proteins |
| ΔXF | Deletion of Xylosyl- and Fucosyltransferase (enzyme activity) |
| CTP | Cytidine Triphosphate |
| CCT | CTP:phosphocholine cytidylyltransferase |
| CRISPR/Cas | Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-Associated Protein |
| IgA | Immunoglobulin A |
| INF-α | Interferon Alfa |
| FDA | Food and Drug Administration |
| GRFT | Griffithsin |
| CV-N | Cyanovirin-N |
| EC50 | Half Maximal Effective Concentration |
| STLs | Sesquiterpene Lactones |
| CiGAS | Germacrene A Synthase from Cichorium |